TTF1 and pulmonary emphysema: In addition, increased expression of TTF-1/NKX2-1 in alveolar type II cells has been found to induce dose-dependent alterations in alveolar morphology, epithelial cell hyperplasia, emphysema, and pulmonary inflammation [22,23].